2015
DOI: 10.1016/j.ijpam.2015.05.004
|View full text |Cite
|
Sign up to set email alerts
|

BCG related complications

Abstract: Background and objectivesAlthough the BCG vaccine is usually a safe vaccine, a number of complications can occur, such as adverse local reactions, regional lymphadenitis, osteomyelitis and disseminated infection in immunocompromised children, with lymphadenitis being the most common complication. Our objective to describe the associated clinical characteristics and outcomes.Materials and methodsThis was a prospective observational study conducted over two year's period.Results100 patients were enrolled with (6… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
13
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 14 publications
3
13
0
Order By: Relevance
“…Many of the severe forms of IEI manifest clinically in the first few months of life (22). Therefore, in some countries, the BCG vaccine is given to infants at a later age (23)(24)(25). Thus, we urge the authorities to refine their statement on BCG and include procedures that assure only healthy children receive the vaccine (26).…”
Section: Discussionmentioning
confidence: 99%
“…Many of the severe forms of IEI manifest clinically in the first few months of life (22). Therefore, in some countries, the BCG vaccine is given to infants at a later age (23)(24)(25). Thus, we urge the authorities to refine their statement on BCG and include procedures that assure only healthy children receive the vaccine (26).…”
Section: Discussionmentioning
confidence: 99%
“…Although BCG vaccine is usually a safe vaccine in children, many complications have been reported, such as adverse local reactions, regional lymphadenitis, osteomyelitis, and disseminated infection in immunocompromised children, with lymphadenitis being one of the most common complications. [ 15 16 ] Intravesical instillation of BCG is widely accepted as an adjuvant immunotherapeutic modality of in situ and superficial transitional cell carcinoma of the urinary bladder. [ 16 ] Literature reports also suggest the use of BCG immunotherapy for the treatment of malignant melanoma.…”
Section: Discussionmentioning
confidence: 99%
“…However, Mycobacterium bovis has been identified in one study[ 19 ] and in iatrogenic disseminated BCG infection. [ 15 20 ]…”
Section: Causative Agentmentioning
confidence: 99%